CAROLINE SHEPPARD: Open Payments
NPI 1144732140 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,227 in 47 payments from 15 companies in 2025. Trend: 2023 $776 · 2024 $618 · 2025 $1,227
Food & beverage: $1,087Education: $140
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $345 |
| Janssen Biotech, Inc. | 6 | $189 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $144 |
| Almirall LLC | 3 | $103 |
| UCB, Inc. | 3 | $94 |
| Incyte Corporation | 3 | $76 |
| Lilly USA, LLC | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Botanix SB Inc | 2 | $37 |
| Journey Medical Corporation | 2 | $35 |
Products named: TREMFYA, RINVOQ, SKYRIZI, Bimzelx, OPZELURA, Klisyri, TALTZ, ILUMYA.
Industry payments across IL — which companies pay providers there.
